Hls Therapeutics Inc opened trading today at $4.70 and closed at $4.75. It traded at a low of $4.70 to a high of $4.75.

Share prices advanced 2.15 percent from the previous day's close of $4.65.

Today across North America, the TSX Composite closed 0.57% at 21947.41, the S&P 500 closed 0.91% at 5064.20, the Dow Jones Industrial Average closed 0.85% at 38225.66 and the Nasdaq Composite closed 1.51% at 15840.96.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 1,900 on 7 total trades. On average, Hls Therapeutics Inc has traded 2,516 shares over 5 days and 9,112 year-to-date.

Trading across the entire TSX saw 3,333 price advancers against 1,844 declines and 124 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, the shares have decreased -10.38% in the last 52 weeks, while this year, they have raised 20.25%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $148.27 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc's consensus rating is "Moderate Buy" based on 5 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..